$images[$image]
Search:
Contracts
Notices
Entities
10% Increment on contract price
Orders and Deliberations
Advanced Search 
Advanced Search 
Advanced Search 
Advanced Search 

Accessory Sanctions

The final decisions on the application of the accessory sanctions provided for in Article 460 of the PCC are published on this Portal and remain here for the whole period of disqualification.

To date there are no records on accessory sanctions for publication.

Contract Details 

Base publication date 07-04-2020
Contract Types Aquisição de bens móveis
Nº de registo do acordo quadro 3430281
Descrição do acordo quadro CP 2018/55
Procedure Type Ao abrigo de acordo-quadro (art.º 259.º)
Description P259-2020-032 - Enoxaparina
Fundamentation Artigo 259.º do Código dos Contratos Públicos
Justification for need to use direct procedure (if applicable) Não aplicável
Contracting Entity – Name, Corp. TAX No. Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E. (506362299)
Contracted Entity - Name, Corp. TAX No. Sanofi - Produtos Farmacêuticos, Lda. (500134960)
Contract object P259-2020-032 Aquisição de medicamentos no âmbito da agregação centralizada 2020 para as instituições do SNS
Centralized Procedure The procedure is intented for needs satisfaction of several entities
CPV 33600000-6, Produtos farmacêuticos
Date of signing of contract 17-03-2020
Contract Value 23.210,77 €
Term of Execution 288 dias
Place of Execution – Country, District, Municipality Portugal
Competitors LAB. FARMACÊUTICOS ROVI, S.A. (980166705)
Sanofi-Produtos Farmacêuticos (500134960)
Notices -
Increases of more then 15% -
Documents -
Observations NA

Contract Execution

Closing date of the agreement -
Total effective price -
Execution time causes of changes -
Causes of changes contract value -